304 related articles for article (PubMed ID: 36119089)
1. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice.
Alves GF; Aimaretti E; Einaudi G; Mastrocola R; de Oliveira JG; Collotta D; Porchietto E; Aragno M; Cifani C; Sordi R; Thiemermann C; Fernandes D; Collino M
Front Immunol; 2022; 13():837180. PubMed ID: 35178052
[TBL] [Abstract][Full Text] [Related]
3. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
[TBL] [Abstract][Full Text] [Related]
4. ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.
Stoppa I; Gigliotti CL; Clemente N; Pantham D; Dianzani C; Monge C; Puricelli C; Rolla R; Sutti S; Renò F; Boldorini R; Boggio E; Dianzani U
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806368
[TBL] [Abstract][Full Text] [Related]
5. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
Front Immunol; 2021; 12():786680. PubMed ID: 34925367
[TBL] [Abstract][Full Text] [Related]
6. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
7. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
8. Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice.
Wang B; Liang S; Wang Y; Zhu XQ; Gong W; Zhang HQ; Li Y; Xia CM
PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003434. PubMed ID: 25590646
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy.
Busch K; Kny M; Huang N; Klassert TE; Stock M; Hahn A; Graeger S; Todiras M; Schmidt S; Chamling B; Willenbrock M; Groß S; Biedenweg D; Heuser A; Scheidereit C; Butter C; Felix SB; Otto O; Luft FC; Slevogt H; Fielitz J
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1653-1668. PubMed ID: 34472725
[TBL] [Abstract][Full Text] [Related]
10. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture.
Cornelius DC; Travis OK; Tramel RW; Borges-Rodriguez M; Baik CH; Greer M; Giachelli CA; Tardo GA; Williams JM
PLoS One; 2020; 15(6):e0234039. PubMed ID: 32555710
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic alteration of CD154/CD40 and its effects on Th1/Th2 polarization in inducible co-stimulator ligand knockout mice infected with Schistosoma japonicum].
Wang Y; Xia CM
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):898-904. PubMed ID: 26679647
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.
Zhan XK; Liu XK; Zhang S; Chen H
Animal Model Exp Med; 2023 Oct; 6(5):464-473. PubMed ID: 37850501
[TBL] [Abstract][Full Text] [Related]
14. [Effects of interleukin-17A on liver and kidney injury and prognosis in septic mice].
Liang Y; Guan C; Meng H; Xie W; Meng X; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):592-597. PubMed ID: 37366124
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL
Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of Schistosoma japonicum cystatin on bacterial sepsis in mice.
Li H; Wang S; Zhan B; He W; Chu L; Qiu D; Li N; Wan Y; Zhang H; Chen X; Fang Q; Shen J; Yang X
Parasit Vectors; 2017 May; 10(1):222. PubMed ID: 28482922
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
Zhou A; Shi C; Fan Y; Zheng Y; Wang J; Liu Z; Xie H; Liu J; Jiao Q
Front Immunol; 2023; 14():1171308. PubMed ID: 37325657
[TBL] [Abstract][Full Text] [Related]
18. ICOS ligand and IL-10 synergize to promote host-microbiota mutualism.
Landuyt AE; Klocke BJ; Duck LW; Kemp KM; Muir RQ; Jennings MS; Blum SI; Tse HM; Lee G; Morrow CD; Elson CO; Maynard CL
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753483
[TBL] [Abstract][Full Text] [Related]
19. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
[TBL] [Abstract][Full Text] [Related]
20. [Ulinastatin protects intestinal mucosal barrier by inhibiting the activation of intestinal NLRP3 inflammasomes in septic rats].
Li X; Yang C; Gulifeire T; Wang Y; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):192-197. PubMed ID: 33729139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
